Baxter, Bayer INDs For European IVIG May Alleviate Blood Product Shortage
Executive Summary
Baxter and Bayer are pursuing emergency-use INDs for IVIG products approved in Europe in an attempt to alleviate the shortage in blood plasma-derived intravenous immune globulin.